You are viewing the site in preview mode

Skip to main content

Table 1 Susceptibility patterns of the rare bacteria isolated from blood cultures of febrile cancer patients at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia; December 2011 and June 2012

From: Rare bacterial isolates causing bloodstream infections in Ethiopian patients with cancer

  Antimicrobial drugs, n (%)
Organisms   AMC AMP C CRO SXT TTC CIP NA CN
Aeromonas hydrophilia (n=4) S - - 1 (25) 1 (25) - - 3 (75) 2 (50) 4 (100)
I - - 1 (25) - - 1 (25) - - -
R 4 (100) 4 (100) 2 (50) 3 (75) 4 (100) 3 (75) 1 (25) 2 (50) -
Chryseomonas luteola (n=2) S - - - - - 2 (100) 2 (100) 2 (100) 2 (100)
I - - - - - - - -  
R 2 (100) 2 (100) 2 (100) 2 (100) 2 (100) - - - -
Pseudomonas fluorescens (n=2) S - - 1 (50) 2 (100)   1 (50) 1 (50) 1 (50) 2 (100)
I - - - - - - - - -
R 2 (100) 2 (100) 1 (50) - 2 (100) 1 (50) 1 (50) 1 (50) -
Serracia ficaria (n=1) S 1 (100) 1 (100) 1 (100) - 1 (100) 1 (100) 1 (100) - -
I - - - - - - - -  
R - - - - - 1 (100) - - 1 (100)
Total (n = 9) S 1 (11.1) 1 (11.1) 3 (33.3)   1 (11.1) 3 (33.3) 7 (77.8) 5 (62.5)a 8 (88.9)
I - - 1 (11.1)   - 1 (11.1 - -  
R 8 (88.9) 8 (88.9) 5 (55.6)   8 (88.9) 5 (55.5) 2 (22.2) 3 (37.5)a 1 (11.1)
  1. a= the denominator is 8, S Sensitive, I Intermediate, R Resistant, AMC Amoxicillin-clavulanic acid, AMP Ampicillin, C Chloramphenicol, CRO Ceftriaxone, SXT Trimethoprim-sulphamethoxazole, TTC Teteracycline, CIP Ciprofloxacin GN Gentamycin, NA Nalidixic acid